Axsome Therapeutics (AXSM) Non-cash Items (2016 - 2026)

Axsome Therapeutics' Non-cash Items history runs 11 years deep, the most recent figure standing at $765631.0 for Q1 2026.

• In Q1 2026, Non-cash Items fell 85.9% year-over-year to $765631.0; the TTM figure through Mar 2026 stood at $765631.0 (down 85.9% YoY), while the FY2025 annual figure was $5.3 million, up 1551.91% from the prior year.
• Non-cash Items came in at $765631.0 for Q1 2026 at Axsome Therapeutics, down from $5.3 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $160.9 million in Q3 2024 to a low of $321478.0 in Q4 2024.
• A 5-year average of $47.1 million and a median of $5.3 million in 2025 frame the typical range for Non-cash Items.
• Across the five-year window, Non-cash Items soared 3497.89% in 2022 and sank 99.66% in 2023, its largest moves.
• Axsome Therapeutics' Non-cash Items stood at $95.7 million in 2022, then tumbled by 99.66% to $323159.0 in 2023, then fell by 0.52% to $321478.0 in 2024, then soared by 1551.91% to $5.3 million in 2025, then slumped by 85.58% to $765631.0 in 2026.
• According to Business Quant data, Non-cash Items over the past three periods registered $765631.0, $5.3 million, and $546116.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison